Anticonvulsant Effects of Topiramate and Lacosamide on Pilocarpine-Induced Status Epilepticus in Rats: A Role of Reactive Oxygen Species and Inflammation

Status epilepticus (SE) is a neurological disorder characterized by a prolonged epileptic activity followed by subsequent epileptogenic processes. The aim of the present study was to evaluate the early effects of topiramate (TPM) and lacosamide (LCM) treatment on oxidative stress and inflammatory da...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of molecular sciences 2021-02, Vol.22 (5), p.2264
Hauptverfasser: Shishmanova-Doseva, Michaela, Peychev, Lyudmil, Yoanidu, Lyubka, Uzunova, Yordanka, Atanasova, Milena, Georgieva, Katerina, Tchekalarova, Jana
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 5
container_start_page 2264
container_title International journal of molecular sciences
container_volume 22
creator Shishmanova-Doseva, Michaela
Peychev, Lyudmil
Yoanidu, Lyubka
Uzunova, Yordanka
Atanasova, Milena
Georgieva, Katerina
Tchekalarova, Jana
description Status epilepticus (SE) is a neurological disorder characterized by a prolonged epileptic activity followed by subsequent epileptogenic processes. The aim of the present study was to evaluate the early effects of topiramate (TPM) and lacosamide (LCM) treatment on oxidative stress and inflammatory damage in a model of pilocarpine-induced SE. Male Wistar rats were randomly divided into six groups and the two antiepileptic drugs (AEDs), TPM (40 and 80 mg/kg, i.p.) and LCM (10 and 30 mg/kg, i.p.), were injected three times repeatedly after pilocarpine administration. Rats were sacrificed 24 h post-SE and several parameters of oxidative stress and inflammatory response have been explored in the hippocampus. The two drugs TPM and LCM, in both doses used, succeeded in attenuating the number of motor seizures compared to the SE-veh group 30 min after administration. Pilocarpine-induced SE decreased the superoxide dismutase (SOD) activity and reduced glutathione (GSH) levels while increasing the catalase (CAT) activity, malondialdehyde (MDA), and IL-1β levels compared to the control group. Groups with SE did not affect the TNF-α levels. The treatment with a higher dose of 30 mg/kg LCM restored to control level the SOD activity in the SE group. The two AEDs, in both doses applied, also normalized the CAT activity and MDA levels to control values. In conclusion, we suggest that the antioxidant effect of TPM and LCM might contribute to their anticonvulsant effect against pilocarpine-induced SE, whereas their weak anti-inflammatory effect in the hippocampus is a consequence of reduced SE severity.
doi_str_mv 10.3390/ijms22052264
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7956388</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2495190746</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-66b3768f3dbadd8fb8626f7c646531d2c51a576807d5f7792500df9e4cc930ee3</originalsourceid><addsrcrecordid>eNpVkV1rFDEUhoNY7IfeeS0Bbx2bSSbJjBfCUra6sNCyrdchm5zULDPJmGQW-1P8t05tLdurc-A8PO-BF6H3NfnMWEfO_W7IlBJOqWheoZO6obQiRMjXB_sxOs15RwhllHdv0DFjQrSybk_Qn0Uo3sSwn_qsQ8FL58CUjKPDt3H0SQ-6ANbB4rU2MevBW8Ax4GvfR6PT6ANUq2AnAxbfFF2mjJej72GcrfPuA97okr_gBd7EHh60G9Cm-D3gq9_3dxDwzQjGQ_6XsQqu18Mc6WN4i46c7jO8e5pn6Mfl8vbie7W--ra6WKwr08i2VEJsmRStY3arrW3dthVUOGlEIzirLTW81nwGiLTcSdlRToh1HTTGdIwAsDP09dE7TtsBrIFQku7VmPyg072K2quXl-B_qru4V7LjgrXtLPj4JEjx1wS5qF2cUph_VrTpeN0R2YiZ-vRImRRzTuCeE2qiHopUh0XO-IfDr57h_82xvxXbnNI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2495190746</pqid></control><display><type>article</type><title>Anticonvulsant Effects of Topiramate and Lacosamide on Pilocarpine-Induced Status Epilepticus in Rats: A Role of Reactive Oxygen Species and Inflammation</title><source>MDPI - Multidisciplinary Digital Publishing Institute</source><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Shishmanova-Doseva, Michaela ; Peychev, Lyudmil ; Yoanidu, Lyubka ; Uzunova, Yordanka ; Atanasova, Milena ; Georgieva, Katerina ; Tchekalarova, Jana</creator><creatorcontrib>Shishmanova-Doseva, Michaela ; Peychev, Lyudmil ; Yoanidu, Lyubka ; Uzunova, Yordanka ; Atanasova, Milena ; Georgieva, Katerina ; Tchekalarova, Jana</creatorcontrib><description>Status epilepticus (SE) is a neurological disorder characterized by a prolonged epileptic activity followed by subsequent epileptogenic processes. The aim of the present study was to evaluate the early effects of topiramate (TPM) and lacosamide (LCM) treatment on oxidative stress and inflammatory damage in a model of pilocarpine-induced SE. Male Wistar rats were randomly divided into six groups and the two antiepileptic drugs (AEDs), TPM (40 and 80 mg/kg, i.p.) and LCM (10 and 30 mg/kg, i.p.), were injected three times repeatedly after pilocarpine administration. Rats were sacrificed 24 h post-SE and several parameters of oxidative stress and inflammatory response have been explored in the hippocampus. The two drugs TPM and LCM, in both doses used, succeeded in attenuating the number of motor seizures compared to the SE-veh group 30 min after administration. Pilocarpine-induced SE decreased the superoxide dismutase (SOD) activity and reduced glutathione (GSH) levels while increasing the catalase (CAT) activity, malondialdehyde (MDA), and IL-1β levels compared to the control group. Groups with SE did not affect the TNF-α levels. The treatment with a higher dose of 30 mg/kg LCM restored to control level the SOD activity in the SE group. The two AEDs, in both doses applied, also normalized the CAT activity and MDA levels to control values. In conclusion, we suggest that the antioxidant effect of TPM and LCM might contribute to their anticonvulsant effect against pilocarpine-induced SE, whereas their weak anti-inflammatory effect in the hippocampus is a consequence of reduced SE severity.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms22052264</identifier><identifier>PMID: 33668718</identifier><language>eng</language><publisher>Switzerland: MDPI AG</publisher><subject>Animal models ; Animals ; Anticonvulsants ; Anticonvulsants - pharmacology ; Anticonvulsants - therapeutic use ; Antiepileptic agents ; Antioxidants ; Biomarkers - metabolism ; Catalase ; Convulsions &amp; seizures ; Cytokines ; Drug dosages ; Epilepsy ; Hippocampus ; Hippocampus - drug effects ; Hippocampus - pathology ; Hippocampus - physiopathology ; IL-1β ; Inflammation ; Inflammation - pathology ; Inflammatory response ; Interleukin-1beta - metabolism ; Lacosamide - pharmacology ; Lacosamide - therapeutic use ; Male ; Malondialdehyde ; Motor Activity - drug effects ; Oxidative stress ; Oxidative Stress - drug effects ; Pilocarpine ; Rats ; Rats, Wistar ; Reactive oxygen species ; Reactive Oxygen Species - metabolism ; Seizures ; Seizures - physiopathology ; Status Epilepticus - chemically induced ; Status Epilepticus - drug therapy ; Status Epilepticus - physiopathology ; Superoxide dismutase ; Topiramate ; Topiramate - pharmacology ; Topiramate - therapeutic use ; Tumor Necrosis Factor-alpha - metabolism ; Tumor necrosis factor-TNF ; Tumor necrosis factor-α</subject><ispartof>International journal of molecular sciences, 2021-02, Vol.22 (5), p.2264</ispartof><rights>2021. This work is licensed under http://creativecommons.org/licenses/by/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2021 by the authors. 2021</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-66b3768f3dbadd8fb8626f7c646531d2c51a576807d5f7792500df9e4cc930ee3</citedby><cites>FETCH-LOGICAL-c478t-66b3768f3dbadd8fb8626f7c646531d2c51a576807d5f7792500df9e4cc930ee3</cites><orcidid>0000-0003-1053-8966 ; 0000-0002-8628-167X ; 0000-0002-6423-5998 ; 0000-0001-6258-410X ; 0000-0003-1640-5099</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956388/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956388/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,27903,27904,53768,53770</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33668718$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Shishmanova-Doseva, Michaela</creatorcontrib><creatorcontrib>Peychev, Lyudmil</creatorcontrib><creatorcontrib>Yoanidu, Lyubka</creatorcontrib><creatorcontrib>Uzunova, Yordanka</creatorcontrib><creatorcontrib>Atanasova, Milena</creatorcontrib><creatorcontrib>Georgieva, Katerina</creatorcontrib><creatorcontrib>Tchekalarova, Jana</creatorcontrib><title>Anticonvulsant Effects of Topiramate and Lacosamide on Pilocarpine-Induced Status Epilepticus in Rats: A Role of Reactive Oxygen Species and Inflammation</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>Status epilepticus (SE) is a neurological disorder characterized by a prolonged epileptic activity followed by subsequent epileptogenic processes. The aim of the present study was to evaluate the early effects of topiramate (TPM) and lacosamide (LCM) treatment on oxidative stress and inflammatory damage in a model of pilocarpine-induced SE. Male Wistar rats were randomly divided into six groups and the two antiepileptic drugs (AEDs), TPM (40 and 80 mg/kg, i.p.) and LCM (10 and 30 mg/kg, i.p.), were injected three times repeatedly after pilocarpine administration. Rats were sacrificed 24 h post-SE and several parameters of oxidative stress and inflammatory response have been explored in the hippocampus. The two drugs TPM and LCM, in both doses used, succeeded in attenuating the number of motor seizures compared to the SE-veh group 30 min after administration. Pilocarpine-induced SE decreased the superoxide dismutase (SOD) activity and reduced glutathione (GSH) levels while increasing the catalase (CAT) activity, malondialdehyde (MDA), and IL-1β levels compared to the control group. Groups with SE did not affect the TNF-α levels. The treatment with a higher dose of 30 mg/kg LCM restored to control level the SOD activity in the SE group. The two AEDs, in both doses applied, also normalized the CAT activity and MDA levels to control values. In conclusion, we suggest that the antioxidant effect of TPM and LCM might contribute to their anticonvulsant effect against pilocarpine-induced SE, whereas their weak anti-inflammatory effect in the hippocampus is a consequence of reduced SE severity.</description><subject>Animal models</subject><subject>Animals</subject><subject>Anticonvulsants</subject><subject>Anticonvulsants - pharmacology</subject><subject>Anticonvulsants - therapeutic use</subject><subject>Antiepileptic agents</subject><subject>Antioxidants</subject><subject>Biomarkers - metabolism</subject><subject>Catalase</subject><subject>Convulsions &amp; seizures</subject><subject>Cytokines</subject><subject>Drug dosages</subject><subject>Epilepsy</subject><subject>Hippocampus</subject><subject>Hippocampus - drug effects</subject><subject>Hippocampus - pathology</subject><subject>Hippocampus - physiopathology</subject><subject>IL-1β</subject><subject>Inflammation</subject><subject>Inflammation - pathology</subject><subject>Inflammatory response</subject><subject>Interleukin-1beta - metabolism</subject><subject>Lacosamide - pharmacology</subject><subject>Lacosamide - therapeutic use</subject><subject>Male</subject><subject>Malondialdehyde</subject><subject>Motor Activity - drug effects</subject><subject>Oxidative stress</subject><subject>Oxidative Stress - drug effects</subject><subject>Pilocarpine</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Reactive oxygen species</subject><subject>Reactive Oxygen Species - metabolism</subject><subject>Seizures</subject><subject>Seizures - physiopathology</subject><subject>Status Epilepticus - chemically induced</subject><subject>Status Epilepticus - drug therapy</subject><subject>Status Epilepticus - physiopathology</subject><subject>Superoxide dismutase</subject><subject>Topiramate</subject><subject>Topiramate - pharmacology</subject><subject>Topiramate - therapeutic use</subject><subject>Tumor Necrosis Factor-alpha - metabolism</subject><subject>Tumor necrosis factor-TNF</subject><subject>Tumor necrosis factor-α</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>8G5</sourceid><sourceid>BENPR</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNpVkV1rFDEUhoNY7IfeeS0Bbx2bSSbJjBfCUra6sNCyrdchm5zULDPJmGQW-1P8t05tLdurc-A8PO-BF6H3NfnMWEfO_W7IlBJOqWheoZO6obQiRMjXB_sxOs15RwhllHdv0DFjQrSybk_Qn0Uo3sSwn_qsQ8FL58CUjKPDt3H0SQ-6ANbB4rU2MevBW8Ax4GvfR6PT6ANUq2AnAxbfFF2mjJej72GcrfPuA97okr_gBd7EHh60G9Cm-D3gq9_3dxDwzQjGQ_6XsQqu18Mc6WN4i46c7jO8e5pn6Mfl8vbie7W--ra6WKwr08i2VEJsmRStY3arrW3dthVUOGlEIzirLTW81nwGiLTcSdlRToh1HTTGdIwAsDP09dE7TtsBrIFQku7VmPyg072K2quXl-B_qru4V7LjgrXtLPj4JEjx1wS5qF2cUph_VrTpeN0R2YiZ-vRImRRzTuCeE2qiHopUh0XO-IfDr57h_82xvxXbnNI</recordid><startdate>20210225</startdate><enddate>20210225</enddate><creator>Shishmanova-Doseva, Michaela</creator><creator>Peychev, Lyudmil</creator><creator>Yoanidu, Lyubka</creator><creator>Uzunova, Yordanka</creator><creator>Atanasova, Milena</creator><creator>Georgieva, Katerina</creator><creator>Tchekalarova, Jana</creator><general>MDPI AG</general><general>MDPI</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-1053-8966</orcidid><orcidid>https://orcid.org/0000-0002-8628-167X</orcidid><orcidid>https://orcid.org/0000-0002-6423-5998</orcidid><orcidid>https://orcid.org/0000-0001-6258-410X</orcidid><orcidid>https://orcid.org/0000-0003-1640-5099</orcidid></search><sort><creationdate>20210225</creationdate><title>Anticonvulsant Effects of Topiramate and Lacosamide on Pilocarpine-Induced Status Epilepticus in Rats: A Role of Reactive Oxygen Species and Inflammation</title><author>Shishmanova-Doseva, Michaela ; Peychev, Lyudmil ; Yoanidu, Lyubka ; Uzunova, Yordanka ; Atanasova, Milena ; Georgieva, Katerina ; Tchekalarova, Jana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-66b3768f3dbadd8fb8626f7c646531d2c51a576807d5f7792500df9e4cc930ee3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Animal models</topic><topic>Animals</topic><topic>Anticonvulsants</topic><topic>Anticonvulsants - pharmacology</topic><topic>Anticonvulsants - therapeutic use</topic><topic>Antiepileptic agents</topic><topic>Antioxidants</topic><topic>Biomarkers - metabolism</topic><topic>Catalase</topic><topic>Convulsions &amp; seizures</topic><topic>Cytokines</topic><topic>Drug dosages</topic><topic>Epilepsy</topic><topic>Hippocampus</topic><topic>Hippocampus - drug effects</topic><topic>Hippocampus - pathology</topic><topic>Hippocampus - physiopathology</topic><topic>IL-1β</topic><topic>Inflammation</topic><topic>Inflammation - pathology</topic><topic>Inflammatory response</topic><topic>Interleukin-1beta - metabolism</topic><topic>Lacosamide - pharmacology</topic><topic>Lacosamide - therapeutic use</topic><topic>Male</topic><topic>Malondialdehyde</topic><topic>Motor Activity - drug effects</topic><topic>Oxidative stress</topic><topic>Oxidative Stress - drug effects</topic><topic>Pilocarpine</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Reactive oxygen species</topic><topic>Reactive Oxygen Species - metabolism</topic><topic>Seizures</topic><topic>Seizures - physiopathology</topic><topic>Status Epilepticus - chemically induced</topic><topic>Status Epilepticus - drug therapy</topic><topic>Status Epilepticus - physiopathology</topic><topic>Superoxide dismutase</topic><topic>Topiramate</topic><topic>Topiramate - pharmacology</topic><topic>Topiramate - therapeutic use</topic><topic>Tumor Necrosis Factor-alpha - metabolism</topic><topic>Tumor necrosis factor-TNF</topic><topic>Tumor necrosis factor-α</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Shishmanova-Doseva, Michaela</creatorcontrib><creatorcontrib>Peychev, Lyudmil</creatorcontrib><creatorcontrib>Yoanidu, Lyubka</creatorcontrib><creatorcontrib>Uzunova, Yordanka</creatorcontrib><creatorcontrib>Atanasova, Milena</creatorcontrib><creatorcontrib>Georgieva, Katerina</creatorcontrib><creatorcontrib>Tchekalarova, Jana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Shishmanova-Doseva, Michaela</au><au>Peychev, Lyudmil</au><au>Yoanidu, Lyubka</au><au>Uzunova, Yordanka</au><au>Atanasova, Milena</au><au>Georgieva, Katerina</au><au>Tchekalarova, Jana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anticonvulsant Effects of Topiramate and Lacosamide on Pilocarpine-Induced Status Epilepticus in Rats: A Role of Reactive Oxygen Species and Inflammation</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2021-02-25</date><risdate>2021</risdate><volume>22</volume><issue>5</issue><spage>2264</spage><pages>2264-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>Status epilepticus (SE) is a neurological disorder characterized by a prolonged epileptic activity followed by subsequent epileptogenic processes. The aim of the present study was to evaluate the early effects of topiramate (TPM) and lacosamide (LCM) treatment on oxidative stress and inflammatory damage in a model of pilocarpine-induced SE. Male Wistar rats were randomly divided into six groups and the two antiepileptic drugs (AEDs), TPM (40 and 80 mg/kg, i.p.) and LCM (10 and 30 mg/kg, i.p.), were injected three times repeatedly after pilocarpine administration. Rats were sacrificed 24 h post-SE and several parameters of oxidative stress and inflammatory response have been explored in the hippocampus. The two drugs TPM and LCM, in both doses used, succeeded in attenuating the number of motor seizures compared to the SE-veh group 30 min after administration. Pilocarpine-induced SE decreased the superoxide dismutase (SOD) activity and reduced glutathione (GSH) levels while increasing the catalase (CAT) activity, malondialdehyde (MDA), and IL-1β levels compared to the control group. Groups with SE did not affect the TNF-α levels. The treatment with a higher dose of 30 mg/kg LCM restored to control level the SOD activity in the SE group. The two AEDs, in both doses applied, also normalized the CAT activity and MDA levels to control values. In conclusion, we suggest that the antioxidant effect of TPM and LCM might contribute to their anticonvulsant effect against pilocarpine-induced SE, whereas their weak anti-inflammatory effect in the hippocampus is a consequence of reduced SE severity.</abstract><cop>Switzerland</cop><pub>MDPI AG</pub><pmid>33668718</pmid><doi>10.3390/ijms22052264</doi><orcidid>https://orcid.org/0000-0003-1053-8966</orcidid><orcidid>https://orcid.org/0000-0002-8628-167X</orcidid><orcidid>https://orcid.org/0000-0002-6423-5998</orcidid><orcidid>https://orcid.org/0000-0001-6258-410X</orcidid><orcidid>https://orcid.org/0000-0003-1640-5099</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2021-02, Vol.22 (5), p.2264
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7956388
source MDPI - Multidisciplinary Digital Publishing Institute; MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Animal models
Animals
Anticonvulsants
Anticonvulsants - pharmacology
Anticonvulsants - therapeutic use
Antiepileptic agents
Antioxidants
Biomarkers - metabolism
Catalase
Convulsions & seizures
Cytokines
Drug dosages
Epilepsy
Hippocampus
Hippocampus - drug effects
Hippocampus - pathology
Hippocampus - physiopathology
IL-1β
Inflammation
Inflammation - pathology
Inflammatory response
Interleukin-1beta - metabolism
Lacosamide - pharmacology
Lacosamide - therapeutic use
Male
Malondialdehyde
Motor Activity - drug effects
Oxidative stress
Oxidative Stress - drug effects
Pilocarpine
Rats
Rats, Wistar
Reactive oxygen species
Reactive Oxygen Species - metabolism
Seizures
Seizures - physiopathology
Status Epilepticus - chemically induced
Status Epilepticus - drug therapy
Status Epilepticus - physiopathology
Superoxide dismutase
Topiramate
Topiramate - pharmacology
Topiramate - therapeutic use
Tumor Necrosis Factor-alpha - metabolism
Tumor necrosis factor-TNF
Tumor necrosis factor-α
title Anticonvulsant Effects of Topiramate and Lacosamide on Pilocarpine-Induced Status Epilepticus in Rats: A Role of Reactive Oxygen Species and Inflammation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-28T10%3A01%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anticonvulsant%20Effects%20of%20Topiramate%20and%20Lacosamide%20on%20Pilocarpine-Induced%20Status%20Epilepticus%20in%20Rats:%20A%20Role%20of%20Reactive%20Oxygen%20Species%20and%20Inflammation&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Shishmanova-Doseva,%20Michaela&rft.date=2021-02-25&rft.volume=22&rft.issue=5&rft.spage=2264&rft.pages=2264-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms22052264&rft_dat=%3Cproquest_pubme%3E2495190746%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2495190746&rft_id=info:pmid/33668718&rfr_iscdi=true